This program is exciting because it will help to ease patients’ financial pressure and stress allowing them to focus on their care.
Allentown, Pa. (PRWEB) July 25, 2016
To help reduce the financial stress, risks, and anxiety that infertility patients often face, Reproductive Medicine Associates of Pennsylvania (RMAPA), a national leader in the field of infertility care, announces its new CareShare 100% IVF Refund Program.
CareShare is a 100% financial guarantee program that offers individuals an opportunity for multiple IVF cycles for a single package price. If after all allowed attempts have been exhausted and there is no live birth and no birth certificate issued, enrolled patients will receive a 100% refund of program fees paid.
RMAPA measures its success by the number of healthy childbirths, instead of the number of positive pregnancy tests. The CareShare program is built on RMAPA’s world-renowned successes.
“This program is exciting because it will help to ease patients’ financial pressure and stress allowing them to focus on their care,” said Melissa Fink, Chief Operating Officer for RMAPA. “Our goal is to give hopeful parents peace of mind and the financial resources to pursue other family building options in the future, if we are unsuccessful.”
For many, the cost of IVF creates a significant financial barrier. In addition to the financial barrier, many individuals are concerned about possible unsuccessful cycles, resulting in increased debt and no baby in their arms. These factors often keep individuals from even making the call to schedule a consultation.
The CareShare program is ideal for patients who don't have insurance coverage for IVF and are paying out-of-pocket, or for those who have waived or exhausted their insurance benefits. Rules and restrictions apply. Eligibility for the program is based on clinical criteria and is only available at RMAPA.
RMAPA is a nationwide leader in successful in vitro fertilization procedures. According to a report released in March 2016 by the Society of Assisted Reproductive Technology (SART), RMAPA has a 72.5% success rate for InVitro Fertilization (IVF) embryo transfers resulting in a live birth, for women under 35. The national average for this age group is 47.4%.*